Table of Contents
MADISON, N.J. — Robitussin has introduced Maximum Strength Cough + Chest Congestion DM, new liquid-filled capsules aimed at controlling cough on the go.
Pfizer Consumer Healthcare said Monday that the new formulation provides the relief of Maximum Strength Robitussin cough liquid in a convenient option for those hitting the road or boarding a plane this holiday season, when more than 40 million Americans are expected to be traveling.
The nondrowsy Robitussin Maximum Strength Cough + Chest Congestion DM relieves cough, chest congestion and mucus via a cough suppressant (dextromethorphan) and expectorant (guaifenesin). It comes in a 20-count box of portable, liquid-filled capsules.
The company noted that travelers can take steps to avoid the consequences of cough, or "COUGHequences," this holiday season by avoiding contact with cold and flu sufferers, washing their hands often, and treating cough, cold and flu symptoms when they appear. Each year in the United States, there are more than 1 billion cases of the common cold and, on average, five to 20% of the population get the flu. Cough is one of the most common symptoms of cold and flu, affecting up to 50% of sufferers.
Robitussin has a variety of products tailored to treat different symptom combinations, including new Maximum Strength Cough + Chest Congestion DM liquid-filled capsules and new Maximum Strength Nighttime Cough DM.
In addition, families can track when cough activity spikes in their local area via the Robitussin COUGHCAST tool. Available on Robitussin.com, the tool can let people know when cough is most likely to strike, so they can be prepared to effectively treat their symptoms, the company said.
